GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 72 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,296 | +33.3% | 3,800 | 0.0% | 0.00% | – |
| Q2 2023 | $5,472 | -31.4% | 3,800 | 0.0% | 0.00% | – |
| Q1 2023 | $7,980 | +85.8% | 3,800 | 0.0% | 0.00% | – |
| Q4 2022 | $4,294 | -28.4% | 3,800 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 3,800 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -16.7% | 3,800 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -25.0% | 3,800 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -46.7% | 3,800 | 0.0% | 0.00% | – |
| Q3 2021 | $15,000 | +25.0% | 3,800 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | +50.0% | 3,800 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -20.0% | 3,800 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | 0.0% | 3,800 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -16.7% | 3,800 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $12,000 | +71.4% | 3,800 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -36.4% | 3,800 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | – | 3,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
| Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
| Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
| WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
| D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
| Virtu Financial LLC | 14,683 | $32,000 | 0.00% |